Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway.

Wu M, Chen W, Lu Y, Zhu G, Hao L, Li YP.

Nat Commun. 2017 Jan 19;8:13700. doi: 10.1038/ncomms13700.

2.

TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease.

Wu M, Chen G, Li YP.

Bone Res. 2016 Apr 26;4:16009. doi: 10.1038/boneres.2016.9. eCollection 2016 Apr 26. Review.

3.

CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity.

Jules J, Chen W, Feng X, Li YP.

J Biol Chem. 2016 Jul 29;291(31):16390-403. doi: 10.1074/jbc.M115.674598. Epub 2016 Apr 20.

PMID:
27129246
4.

Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology.

Li S, Hao L, Wang L, Lu Y, Li Q, Zhu Z, Shao JZ, Chen W.

PLoS One. 2015 Aug 14;10(8):e0134903. doi: 10.1371/journal.pone.0134903. eCollection 2015 Aug 14.

5.

Ac45 silencing mediated by AAV-sh-Ac45-RNAi prevents both bone loss and inflammation caused by periodontitis.

Zhu Z, Chen W, Hao L, Zhu G, Lu Y, Li S, Wang L, Li YP.

J Clin Periodontol. 2015 Jul;42(7):599-608. doi: 10.1111/jcpe.12415. Epub 2015 Jun 11.

6.

In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.

McGarvey PB, Suzek BE, Baraniuk JN, Rao S, Conkright B, Lababidi S, Sutherland A, Forshee R, Madhavan S.

BMC Immunol. 2014 Dec 9;15:61. doi: 10.1186/s12865-014-0061-0.

7.

RNAi-mediated silencing of Atp6i and Atp6i haploinsufficiency prevents both bone loss and inflammation in a mouse model of periodontal disease.

Jiang H, Chen W, Zhu G, Zhang L, Tucker B, Hao L, Feng S, Ci H, Ma J, Wang L, Stashenko P, Li YP.

PLoS One. 2013;8(4):e58599. doi: 10.1371/journal.pone.0058599. Epub 2013 Apr 5.

8.

An extended nomenclature for mammalian V-ATPase subunit genes and splice variants.

Miranda KC, Karet FE, Brown D.

PLoS One. 2010 Mar 10;5(3):e9531. doi: 10.1371/journal.pone.0009531.

9.

Signaling networks that control the lineage commitment and differentiation of bone cells.

Soltanoff CS, Yang S, Chen W, Li YP.

Crit Rev Eukaryot Gene Expr. 2009;19(1):1-46. Review.

10.
11.
12.
13.

Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis.

Taranta A, Migliaccio S, Recchia I, Caniglia M, Luciani M, De Rossi G, Dionisi-Vici C, Pinto RM, Francalanci P, Boldrini R, Lanino E, Dini G, Morreale G, Ralston SH, Villa A, Vezzoni P, Del Principe D, Cassiani F, Palumbo G, Teti A.

Am J Pathol. 2003 Jan;162(1):57-68.

14.

A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats.

Visentin L, Dodds RA, Valente M, Misiano P, Bradbeer JN, Oneta S, Liang X, Gowen M, Farina C.

J Clin Invest. 2000 Jul;106(2):309-18.

15.

Novel treatments for osteoporosis.

Canalis E.

J Clin Invest. 2000 Jul;106(2):177-9. No abstract available.

16.

The vacuolar H+-ATPase: a universal proton pump of eukaryotes.

Finbow ME, Harrison MA.

Biochem J. 1997 Jun 15;324 ( Pt 3):697-712. Review.

Supplemental Content

Support Center